No evidence for functional inactivation of wild-type p53 protein by MDM2 overexpression in gastric carcinogenesis
- 1 September 1998
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 186 (1) , 36-40
- https://doi.org/10.1002/(sici)1096-9896(199809)186:1<36::aid-path150>3.0.co;2-r
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- MDM2 expression in lymphoid cells and reactive and neoplastic lymphoid tissue. Comparative study with p53 expressionThe Journal of Pathology, 1995
- Comparative analysis of p53 gene mutations and protein accumulation in human non‐small‐cell lung cancerInternational Journal of Cancer, 1995
- Oncogene Amplification in Urothelial Cancers With p53 Gene Mutation or MDM2 AmplificationJNCI Journal of the National Cancer Institute, 1994
- MDM2 and p53: a Question of BalanceJNCI Journal of the National Cancer Institute, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- The p53-mdm-2 autoregulatory feedback loop.Genes & Development, 1993
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- p53 Mutations in Human CancersScience, 1991
- The p53 tumour suppressor geneNature, 1991